FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 162 of 162

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
TRVI Nasdaq Trevi Therapeutics, Inc. 2834
TVTX Nasdaq Travere Therapeutics, Inc. 2834
TXMD Nasdaq TherapeuticsMD, Inc. 2834
UCBJY Over the counter UCB SA 2834
VIR Nasdaq Vir Biotechnology, Inc. 2834
VNDA Nasdaq Vanda Pharmaceuticals Inc. 2834
VRCA Nasdaq Verrica Pharmaceuticals Inc. 2834
VYNE Nasdaq VYNE Therapeutics Inc. 2834
WHWK Nasdaq Whitehawk Therapeutics, Inc. 2834
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2834
YCBD NYSE American cbdMD, Inc. 2834
ZURA Nasdaq Zura Bio Limited 2834
Results 150 through 162 of 162